Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Seres Therapeutics (MCRB) over the last 11 years, with Q3 2025 value amounting to $22.4 million.

  • Seres Therapeutics' Total Current Liabilities fell 6540.5% to $22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.4 million, marking a year-over-year decrease of 6540.5%. This contributed to the annual value of $41.2 million for FY2024, which is 5821.77% down from last year.
  • Latest data reveals that Seres Therapeutics reported Total Current Liabilities of $22.4 million as of Q3 2025, which was down 6540.5% from $30.9 million recorded in Q2 2025.
  • In the past 5 years, Seres Therapeutics' Total Current Liabilities registered a high of $108.3 million during Q2 2024, and its lowest value of $22.4 million during Q3 2025.
  • For the 5-year period, Seres Therapeutics' Total Current Liabilities averaged around $70.4 million, with its median value being $79.2 million (2023).
  • In the last 5 years, Seres Therapeutics' Total Current Liabilities surged by 10666.59% in 2021 and then tumbled by 7142.65% in 2025.
  • Quarter analysis of 5 years shows Seres Therapeutics' Total Current Liabilities stood at $82.3 million in 2021, then rose by 4.06% to $85.6 million in 2022, then grew by 15.26% to $98.7 million in 2023, then tumbled by 58.22% to $41.2 million in 2024, then tumbled by 45.59% to $22.4 million in 2025.
  • Its Total Current Liabilities stands at $22.4 million for Q3 2025, versus $30.9 million for Q2 2025 and $31.3 million for Q1 2025.